Similarly, Lee et al, reported that the protein expression of ERCC1 in 77 SCLC patients treated with platinum-based doublets, was associated with poor OS, especially in patients with LS-SCLC indicating that high expression of ERCC1 can be a prognostic biomarker for this group of patients [37]. Here, ERCC1 is linked to small cell lung carcinoma.